Sulfalene Explained

Sulfalene (INN, USAN) or sulfametopyrazine (BAN) is a long-acting sulfonamide antibacterial used for the treatment of chronic bronchitis, urinary tract infections and malaria. As of 2014 there were only two countries in which it is currently still marketed: Thailand and Ireland.[1]

It was discovered by researchers at Farmitalia and first published in 1960 and was marketed as Kelfizina.[2] [3]

See also

References

  1. Web site: Sulfametopyrazine. Martindale: The Complete Drug Reference. Pharmaceutical Press. 9 May 2013. 28 March 2014. Brayfield A .
  2. Baruffa G . Clinical trials in Plasmodium falciparum malaria with a long-acting sulphonamide . Transactions of the Royal Society of Tropical Medicine and Hygiene . 60 . 2 . 222–4 . 1966 . 5332105 . 10.1016/0035-9203(66)90030-7 .
  3. Per prior citation, the first publication: Camerino B, Palamidessi G . 1960 . Derivati della parazina II. Sulfonamdopir . it . Gazz Chim Ital . 90 . 1802–1815 .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Sulfalene".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.